{
  "query": "proteinuria baseline egfr from",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT01978951",
          "briefTitle": "Effectiveness of Integrated Care on Delaying Chronic Kidney Disease Progression in Rural Communities of Thailand"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-07"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 443,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05138133",
          "briefTitle": "Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 360,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03021499",
          "briefTitle": "Aurinia Renal Response in Active Lupus With Voclosporin"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 358,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05679336",
          "briefTitle": "Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Membranous Nephropathy - PLA2R Induced"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06851845",
          "briefTitle": "Clinical Outcomes of C3 Glomerulopathy and IC-MPGN in Russia: Hybrid Retrospective - Prospective Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-02-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Diseases"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "0 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06013865",
          "briefTitle": "Empagliflozin Treatment in Kidney Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Kidney Transplant", "Chronic Kidney Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 264,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02055079",
          "briefTitle": "Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-04"
          },
          "completionDateStruct": {
            "date": "2019-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Polycystic Kidney, Type 1 Autosomal Dominant Disease", "Polycystic Kidney, Type 2 Autosomal Dominant Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 68,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06963827",
          "briefTitle": "A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-01-14",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 347,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03831464",
          "briefTitle": "Metformin as RenoProtector of Progressive Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 290,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04943302",
          "briefTitle": "Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Amyloidosis", "Light Chain (AL) Amyloidosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06153147",
          "briefTitle": "KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors (CCS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2039-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Childhood Cancer", "Chronic Kidney Diseases", "Hypertension", "Acute Kidney Injury", "Nephrotoxicity"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04578834",
          "briefTitle": "Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 518,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01544491",
          "briefTitle": "Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-08-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-09-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 106,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06686758",
          "briefTitle": "Efficacy and Safety of LC-Z300-01 on Proteinuria in Diabetic Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Kidney Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06939816",
          "briefTitle": "Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-11-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Disease Stage 2", "Chronic Kidney Disease Stage 3", "Metabolic Dysfunction-Associated Steatohepatitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07267208",
          "briefTitle": "A Prospective Study to Evaluate the Efficacy and Safety of Entecavir ODT Conversion in Stable Liver Transplant Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatitis B Virus", "Liver Transplant"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02036554",
          "briefTitle": "Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-03"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney; Complications, Allograft"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 234,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01282073",
          "briefTitle": "Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03"
          },
          "completionDateStruct": {
            "date": "2016-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Glomerulonephritis, Membranous"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04026776",
          "briefTitle": "Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Salt; Excess", "Blood Pressure Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "22 Years",
          "maximumAge": "33 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02482974",
          "briefTitle": "Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07"
          },
          "completionDateStruct": {
            "date": "2016-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Liver Transplant Recipients"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01609673",
          "briefTitle": "Study of Everolimus in de Novo Renal Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-03"
          },
          "completionDateStruct": {
            "date": "2013-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "End Stage Renal Failure With Renal Transplant"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01955187",
          "briefTitle": "Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-06-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "MEMBRANOUS NEPHROPATHY"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 86,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06405100",
          "briefTitle": "Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Minimal Change Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03736551",
          "briefTitle": "Intermittent Low Energy Diet in CKD: MIX UP Feasibility Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-06-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Diseases", "Obesity"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05759754",
          "briefTitle": "Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Proteinuria", "Kidney Diseases", "Hereditary Nephropathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04835883",
          "briefTitle": "Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-20",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04561986",
          "briefTitle": "TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Antibody-mediated Rejection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05125068",
          "briefTitle": "Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["IgA Nephropathy", "IgAN"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07219121",
          "briefTitle": "Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Proteinuria", "Immunoglobulin A (IgA) Nephropathy", "Focal Segmental Glomerulosclerosis", "Kidney Transplant"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06926244",
          "briefTitle": "RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy (IgAN)"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 800,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02863510",
          "briefTitle": "Renal Sympathetic Denervation in Moderate to Severe Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-09"
          },
          "completionDateStruct": {
            "date": "2016-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hypertension", "Chronic Kidney Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03453619",
          "briefTitle": "Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["IgA Nephropathy", "Lupus Nephritis", "Membranous Nephropathy", "C3 Glomerulonephritis", "Dense Deposit Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05268289",
          "briefTitle": "Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 240,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06942910",
          "briefTitle": "A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Disease With High Proteinuria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 224,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00657059",
          "briefTitle": "Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-09"
          },
          "completionDateStruct": {
            "date": "2019-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 151,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05755386",
          "briefTitle": "Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IC-MPGN"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 106,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04868838",
          "briefTitle": "Daratumumab to Treat Active Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03255447",
          "briefTitle": "Peptide GAM Immunoadsorption Therapy in Autoimmune Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-04-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Autoimmune Membranous Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06717815",
          "briefTitle": "Phase IIa Study for IPG11406 in Patients With Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04-22",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05041829",
          "briefTitle": "Dietary Sodium Intake and Blood Pressure in Living Kidney Donors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hypertension", "Living Kidney Donor", "Dietary Sodium Intake"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04889183",
          "briefTitle": "SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Obesity", "Albuminuria"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 125,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05894512",
          "briefTitle": "Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Membranous Nephropathy", "Membranous Nephropathy - PLA2R Induced", "Membranous Nephropathy - THSD7A Induced"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03118739",
          "briefTitle": "Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-08-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hyperuricemia", "Albuminuria", "Type 2 Diabetes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03386539",
          "briefTitle": "Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Pediatric Heart Transplantation", "Immunosuppression", "Chronic Kidney Diseases", "Cardiac Allograft Vasculopathy", "Heart Transplant Failure and Rejection", "Post-transplant Lymphoproliferative Disorder", "Heart Transplant Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 211,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05650164",
          "briefTitle": "Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Cell Carcinoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 171,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02471599",
          "briefTitle": "Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03"
          },
          "completionDateStruct": {
            "date": "2023-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01762852",
          "briefTitle": "Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04"
          },
          "completionDateStruct": {
            "date": "2014-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Glomerulonephritis, Membranous"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06828562",
          "briefTitle": "GENomic Predictors in A Multi-Ethnic Population With Kidney Disease Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2050-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05696613",
          "briefTitle": "A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Membranous Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 148,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04645589",
          "briefTitle": "Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07015983",
          "briefTitle": "A Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-06-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lupus Erythematosus, Systemic", "Lupus Nephritis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 89,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03806452",
          "briefTitle": "SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Sickle Cell Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 86,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06120673",
          "briefTitle": "REmission in Membranous Nephropathy International Trial (REMIT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-31",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Membranous Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05003986",
          "briefTitle": "Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Focal Segmental Glomerulosclerosis", "Minimal Change Disease", "Immunoglobulin A Nephropathy", "IgA Vasculitis", "Alport Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 67,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01581073",
          "briefTitle": "PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-12-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Disease", "Diabetes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 476,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06150651",
          "briefTitle": "Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "SLE (Systemic Lupus)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05969522",
          "briefTitle": "Stratified Therapy on Pediatric AAGN"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "ANCA-Associated Glomerulonephritis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03425994",
          "briefTitle": "Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Hepatitis B in HIV Patient", "Kidney Injury", "Bone Diseases"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 275,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04573478",
          "briefTitle": "Atrasentan in Patients With IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-18",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["IgA Nephropathy", "Immunoglobulin A Nephropathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 404,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03168906",
          "briefTitle": "Renal AL Amyloid Involvement and NEOD001"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Amyloidosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07059026",
          "briefTitle": "Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Thrombotic Microangiopathy"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03703908",
          "briefTitle": "A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Focal Segmental Glomerulosclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03448692",
          "briefTitle": "A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Focal Segmental Glomerulosclerosis (FSGS)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 47,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07182227",
          "briefTitle": "PS-002 for the Treatment of IgA Nephropathy in Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Immunoglobulin A (IgA) Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06824987",
          "briefTitle": "Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "APOL1-Mediated Kidney Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 96,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06780865",
          "briefTitle": "Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Disease(CKD)", "Nocturnal Hypertension"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05196035",
          "briefTitle": "A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Disease", "Proteinuria"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 219,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05012865",
          "briefTitle": "Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Cell Carcinoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06962800",
          "briefTitle": "A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Membranous Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 180,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06969807",
          "briefTitle": "Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Kidney Disease (DKD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02426684",
          "briefTitle": "Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-06-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-11-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05881447",
          "briefTitle": "Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Diseases", "Type 2 Diabetes Mellitus", "Arterial Hypertension", "Obesity", "Cardiovascular Diseases", "HIV Infections", "Anemia", "Underweight", "Infections", "Albuminuria", "Dyslipidemias"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03949855",
          "briefTitle": "Belimumab With Rituximab for Primary Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Membranous Nephropathy", "Nephrotic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 58,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06545461",
          "briefTitle": "Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1998-06-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-10-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Diseases", "Cardiovascular Diseases", "Hypertension"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 108,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06226896",
          "briefTitle": "Effects of Dapagliflozin on Progression of Alport Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Alport Syndrome"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 222,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04702256",
          "briefTitle": "Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lupus Nephritis", "Systemic Lupus Erythematosus (SLE)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 196,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05553496",
          "briefTitle": "Assessment of Rituximab Therapeutic Response Versus Conventional Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-25",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Pharmacological Action"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06209736",
          "briefTitle": "Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["C3 Glomerulopathy", "Idiopathic Immune Complex-Mediated Glomerulonephritis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04492722",
          "briefTitle": "A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 613,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "130 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03536754",
          "briefTitle": "A Study of CCX140-B in Subjects With FSGS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-02-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["FSGS", "Focal Segmental Glomerulosclerosis", "Glomerulosclerosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03551119",
          "briefTitle": "Physical Activity in Renal Disease (PAIRED): The Effect on Hypertension"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02592798",
          "briefTitle": "Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Nephrotic Syndrome", "Focal Segmental Glomerulosclerosis", "Minimal Change Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05888909",
          "briefTitle": "Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetic Nephropathy Type 2", "Diabetic Kidney Disease", "Type 2 Diabetes"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 2000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06099236",
          "briefTitle": "A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atypical Hemolytic Uremic Syndrome(aHUS)"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1070,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06712407",
          "briefTitle": "Efficacy and Safety of Extended TARPEYO Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03201939",
          "briefTitle": "Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["HIV/AIDS", "Albuminuria", "Kidney Diseases", "Genetic Predisposition"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02818192",
          "briefTitle": "Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Type 2 Diabetes", "Proteinuria", "Stress", "Nephropathy"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "10 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06564142",
          "briefTitle": "Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-01-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Immunoglobulin A Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 605,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03019185",
          "briefTitle": "A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Alport Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 187,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02000440",
          "briefTitle": "A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07-01"
          },
          "completionDateStruct": {
            "date": "2016-05-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Glomerulosclerosis, Focal Segmental"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02662283",
          "briefTitle": "Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05"
          },
          "completionDateStruct": {
            "date": "2016-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IGA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 75,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07111338",
          "briefTitle": "Telitacicept for PGNMID: A Single-Arm Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03373461",
          "briefTitle": "Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05593575",
          "briefTitle": "Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Kidney Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 305,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02384317",
          "briefTitle": "Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-06-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Immunoglobulin A Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04342325",
          "briefTitle": "The Clinical Trial of ADR-001 for IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-03-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Glomerulonephritis , IGA"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02403115",
          "briefTitle": "Prediction of Outcome of Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10"
          },
          "completionDateStruct": {
            "date": "2022-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 800,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02765776",
          "briefTitle": "An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens in Aged HIV Patients (RalAge)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05"
          },
          "completionDateStruct": {
            "date": "2016-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02399462",
          "briefTitle": "Acthar for Treatment of Post-transplant FSGS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-07-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["FSGS", "Renal Transplantation", "Kidney Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02547220",
          "briefTitle": "A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Antibody-Mediated Rejection (AMR)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT05732727",
          "briefTitle": "Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Disease(CKD)", "Uncontrolled Hypertension"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 720,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05457283",
          "briefTitle": "A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-02-27",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Disease", "Proteinuria", "Children"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05942027",
          "briefTitle": "Role of Coenzyme Q10 in Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-07-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06425705",
          "briefTitle": "Impact of Silymarin Adjunct Therapy on Proteinuria in Type 2 Diabetic Patients on RAS Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "35 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02765594",
          "briefTitle": "Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Primary IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 98,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06994845",
          "briefTitle": "Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Immunoglobulin A Nephropathy (IgAN)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06064929",
          "briefTitle": "A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02369549",
          "briefTitle": "Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 518,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03539627",
          "briefTitle": "Azilsartan Medoxomil in Hypertensive pAtients With Stable Ischemic Heart Disease and DiabEtes MEllitus."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-04-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Arterial Hypertension", "Diabetes Mellitus", "Stable Chronic Angina"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 184,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01560052",
          "briefTitle": "Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-05-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Glomerulonephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 503,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04940819",
          "briefTitle": "A Mobile Application Based Dietary Self Management Intervention in Chinese Chronic Kidney Disease Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Renal Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9863,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03385564",
          "briefTitle": "An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 69,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03041987",
          "briefTitle": "Chinese Cohort Study of Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Insufficiency, Chronic"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 5000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "74 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02605525",
          "briefTitle": "Efficacy and Safety of SM101 in the Treatment of IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Immunoglobulin A Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03061214",
          "briefTitle": "Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-04-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes", "Diabetes Mellitus, Type 2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 868,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05596708",
          "briefTitle": "Study of Telitacicept in Patients With Refractory IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05067127",
          "briefTitle": "Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["C3G", "IC-MPGN", "C3 Glomerulopathy", "C3 Glomerulonephritis", "Complement 3 Glomerulopathy", "Complement 3 Glomerulopathy (C3G)", "Complement 3 Glomerulonephritis", "Dense Deposit Disease", "DDD", "Membranoproliferative Glomerulonephritis", "Membranoproliferative Glomerulonephritis (MPGN)", "Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 124,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07175285",
          "briefTitle": "A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and 2 Immunosuppressants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-11-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus (SLE)"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 223,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06983028",
          "briefTitle": "Atacicept in Multiple Glomerular Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["pMN", "IgAN", "Nephrotic Syndrome", "MCD", "FSGS"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "10 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03774784",
          "briefTitle": "A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Amyloidosis", "Leukocyte Chemotactic Factor 2 Amyloidosis"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06377228",
          "briefTitle": "A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-13",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-09-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Refractory Lupus Nephritis", "Refractory Systemic Sclerosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02183909",
          "briefTitle": "Connecting Resources for Urban Sexual Health"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["HIV", "Sexually Transmitted Infections"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 378,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "29 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06864104",
          "briefTitle": "A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hypertension"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 206,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05214105",
          "briefTitle": "The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Sickle Cell Disease", "Kidney Diseases, Chronic"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 400,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06826664",
          "briefTitle": "Institution of an Italian Multicenter Database of Patients Affected by Diseases of Phosphate Metabolism"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2035-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Phosphate Deficiency", "Phosphate Overload"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06471621",
          "briefTitle": "Precision Medicine in Cardiovascular Surgery Associated Acute Kidney Injury"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Kidney Injury", "Surgery-Complications", "Frailty"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05268926",
          "briefTitle": "TreatIng Microalbuminuria Over 24 Weeks in Subjects With or Without Type 2 Diabetes or HYpertension"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Albuminuria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04817618",
          "briefTitle": "Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "C3G"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 98,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02002585",
          "briefTitle": "Renal Protection Using Sympathetic Denervation in Patients With Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11"
          },
          "completionDateStruct": {
            "date": "2018-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Arterial Hypertension", "Chronic Renal Insufficiency"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03918447",
          "briefTitle": "A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Autosomal Dominant Polycystic Kidney", "ADPKD"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 667,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03459443",
          "briefTitle": "A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["C3 Glomerulonephritis", "C3 Glomerulopathy", "Immune Complex Membranoproliferative Glomerulonephritis", "IC-MPGN", "Dense Deposit Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00153023",
          "briefTitle": "1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-04"
          },
          "completionDateStruct": {
            "date": "2005-12"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetic Nephropathies", "Hypertension"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 885
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03166696",
          "briefTitle": "Acute Myocardial Infarction and Acute Cerebral Infarction (AMIAC) Registry and Follow-up"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2000-01-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Myocardial Infarction", "Cerebral Infarction", "Chronic Kidney Diseases", "Mortality"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 30000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02525263",
          "briefTitle": "Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07"
          },
          "completionDateStruct": {
            "date": "2017-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Disease", "Type 2 Diabetes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04491552",
          "briefTitle": "TruGraf Long-term Clinical Outcomes Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Transplant Rejection"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 2000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06499948",
          "briefTitle": "Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients with Alport Syndrome (COMBINE-ALPORT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Alport Syndrome", "Thin Basement Membrane Disease", "Alport Nephropathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01777932",
          "briefTitle": "AVAREG Study: An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-12"
          },
          "completionDateStruct": {
            "date": "2012-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Breast Cancer"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 220,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02052219",
          "briefTitle": "BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10"
          },
          "completionDateStruct": {
            "date": "2021-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02639260",
          "briefTitle": "A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-06-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05707377",
          "briefTitle": "A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Membranous Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 178,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05714670",
          "briefTitle": "The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lupus Nephritis", "SLE Nephritis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05201469",
          "briefTitle": "VIBRANT: VIB4920 for Active Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 74,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06406205",
          "briefTitle": "A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 270,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06528405",
          "briefTitle": "The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Kidney Injury"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 264,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06295770",
          "briefTitle": "Obinutuzumab in Treatment of Fibrillary Glomerulonephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Fibrillary Glomerulonephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06676579",
          "briefTitle": "Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy (IgAN)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01714817",
          "briefTitle": "Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 695,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06474273",
          "briefTitle": "TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Rejection; Transplant, Kidney", "Rejection; Transplant, Pancreas"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 540,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01356849",
          "briefTitle": "Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-04"
          },
          "completionDateStruct": {
            "date": "2012-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Disease", "Diabetic Nephropathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 149,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01427049",
          "briefTitle": "The Effect of Renal Denervation on Biological Variables"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-08"
          },
          "completionDateStruct": {
            "date": "2014-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hypertension"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04893733",
          "briefTitle": "Intravenous Administration of Vitamin B Complex Improves Renal Recovery in Patients With AKI"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Kidney Injury"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 260,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00296374",
          "briefTitle": "Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-02"
          },
          "completionDateStruct": {
            "date": "2009-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 353,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04424862",
          "briefTitle": "Multitarget Therapy for Idiopathic Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Efficacy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07024563",
          "briefTitle": "Study of Ravulizumab in Pediatric Participants With Primary IgAN"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-11-27",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["IgAN", "IgAVN", "Immunoglobulin A Nephropathy", "Immunoglobulin A Vasculitis Associated Nephritis", "Henoch-schonlein Purpura Nephritis", "IgA Vasculitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04974138",
          "briefTitle": "China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hypertension", "MTHFR 677 CC or CT Genotype", "Elevated Plasma Homocysteine (Hcy10mol/L)", "Insufficient Plasma Folate Levels (<12ng/mL)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years",
          "maximumAge": "74 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05655728",
          "briefTitle": "Treatment With Metformin in Chinese Children With Alport Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-03",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-04-20",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Alport Syndrome", "Metformin"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "10 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03667300",
          "briefTitle": "Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Type2 Diabetes Mellitus", "Albuminuria", "Renal Insufficiency"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 209,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04451356",
          "briefTitle": "Romanian Kidney Transplant Cardiovascular Risk Registry"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Kidney Transplant; Complications", "Cardiovascular Diseases"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07074951",
          "briefTitle": "Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-03-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Primary IgA-nephropathy", "High-risk", "Caucasians"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 240,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02115503",
          "briefTitle": "A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07"
          },
          "completionDateStruct": {
            "date": "2020-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Transplant Recipients With Anti-HLA Antibodies"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02010242",
          "briefTitle": "Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-10"
          },
          "completionDateStruct": {
            "date": "2015-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes Mellitus With Diabetic Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 136,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02632786",
          "briefTitle": "The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03"
          },
          "completionDateStruct": {
            "date": "2018-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "AL Amyloidosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 129,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04877288",
          "briefTitle": "A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2034-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Allograft Recipients"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 102,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04073927",
          "briefTitle": "Effect of Butyrate on Inflammation and Albuminuria in Patients With Albuminuria, Type 1 Diabetes and Intestinal Inflammation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus, Type 1", "Albuminuria"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05329090",
          "briefTitle": "Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-16",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Vasculitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 75,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06454110",
          "briefTitle": "Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04974151",
          "briefTitle": "China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hypertension", "MTHFR 677 TT Genotype"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "45 Years",
          "maximumAge": "74 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04818216",
          "briefTitle": "Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["SARS-CoV-2 Infection", "Acute Kidney Injury"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07187713",
          "briefTitle": "ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hypertensive Nephropathy", "Auto Immune Disorders", "Chronic Kidney Disease", "Chronc Kidney Disease Stage 5", "Chronic Kidney Disease (Stage 3-4)", "Chronic Kidney Disease (Stages 4 and 5)", "Microalbuminuria", "Diabetic Nephropathies"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06774664",
          "briefTitle": "A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 99,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07029139",
          "briefTitle": "A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-03-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Membranous Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 156,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06291376",
          "briefTitle": "Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-12-23",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Immunoglobulin A Nephropathy", "IgAN"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 510,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02231125",
          "briefTitle": "Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-09"
          },
          "completionDateStruct": {
            "date": "2017-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1600,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04042623",
          "briefTitle": "Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04702997",
          "briefTitle": "A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03550859",
          "briefTitle": "HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Disease", "Proteinuria"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 374,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06935357",
          "briefTitle": "A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-06-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Immunoglobulin A Nephropathy (IgAN)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 454,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05970341",
          "briefTitle": "Kidney Health: Eat Well, Live Well"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 330,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03994783",
          "briefTitle": "Transplant Antibody-Mediated Rejection: Guiding Effective Treatments"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-01-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Kidney Transplant Rejection", "Antibody-mediated Rejection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06094920",
          "briefTitle": "Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-10-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus Type 2 With Proteinuria", "Diabetes Mellitus, Type 2", "Diabetes Mellitus", "Diabetes", "Diabetes Complications", "Albuminuria", "Chronic Kidney Diseases", "Chronic Kidney Disease Due to Type 2 Diabetes Mellitus", "Chronic Kidney Disease stage3", "Chronic Kidney Disease stage4", "CKD", "CKD Stage 3", "CKD Stage 4"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05546047",
          "briefTitle": "A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-27",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Fibrillary Glomerulonephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02112838",
          "briefTitle": "Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10"
          },
          "completionDateStruct": {
            "date": "2018-11-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "IGA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 76,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00920764",
          "briefTitle": "A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-06"
          },
          "completionDateStruct": {
            "date": "2010-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Disease", "Diabetic Nephropathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 92,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05321706",
          "briefTitle": "DAPAgliflozin for Renal Protection in Heart Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Heart Transplant Failure", "Kidney Failure"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 430,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05782933",
          "briefTitle": "Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Membranous Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01665391",
          "briefTitle": "A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-08"
          },
          "completionDateStruct": {
            "date": "2014-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Focal Segmental Glomerulosclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02795676",
          "briefTitle": "Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Fabry Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05839314",
          "briefTitle": "Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Nephropathy", "Glomerular Diseases", "Idiopathic Membranous Nephropathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 480,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06117852",
          "briefTitle": "Chronic Kidney Disease Registry Platform Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Diseases"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 5000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02173106",
          "briefTitle": "A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06"
          },
          "completionDateStruct": {
            "date": "2016-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Idiopathic Membranous Nephropathy", "Proteinuria", "Spontaneous Remission", "Steroid Nephropathy", "Cyclosporin Overdose"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 180,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00658359",
          "briefTitle": "Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Transplantation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 178,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07214818",
          "briefTitle": "SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-09-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Nephrotic Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 75,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02437890",
          "briefTitle": "A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07"
          },
          "completionDateStruct": {
            "date": "2018-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Erythematosus, Systemic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 312,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03188887",
          "briefTitle": "Treatment of IgA Nephropathy According to Renal Lesions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05684159",
          "briefTitle": "Study of NM8074 in Patients with AHUS with Evidence of Ongoing Thrombotic Microangiopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "AHUS - Atypical Hemolytic Uremic Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04376827",
          "briefTitle": "A Study of Guselkumab in Participants With Active Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03488368",
          "briefTitle": "Longterm Renal Oucomes of STOP-IgAN Trial Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 148,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06971874",
          "briefTitle": "The Outcome of Chronic Kidney Disease Patients With Obstructive Sleep Apnea Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Diseases", "OSAS (Obstructive Sleep Apneas Syndrome)"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 356,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04531397",
          "briefTitle": "Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Proteinuria", "Chronic Kidney Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01610492",
          "briefTitle": "A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07-01"
          },
          "completionDateStruct": {
            "date": "2016-09-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Glomerulonephritis, Membranous"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      }
    ],
    "protocolSection.2": [
      {
        "identificationModule": {
          "nctId": "NCT06047171",
          "briefTitle": "Rescue of Nephrons With ALE.F02 (RENAL-F02)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Glomerulonephritis Rapidly Progressive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01265992",
          "briefTitle": "Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-02"
          },
          "completionDateStruct": {
            "date": "2012-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Secondary Hyperparathyroidism", "Chronic Kidney Disease"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05532111",
          "briefTitle": "Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Efficacy and Safety"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03236792",
          "briefTitle": "Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "AL Amyloidosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06838416",
          "briefTitle": "Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Type 2 Diabetes Mellitus", "Chronic Kidney Disease", "Renal Function"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06460987",
          "briefTitle": "Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Finerenone", "IgA Nephropathy", "Proteinuria", "Safety Issues"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 245,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02770170",
          "briefTitle": "Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 121,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02141672",
          "briefTitle": "AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06"
          },
          "completionDateStruct": {
            "date": "2017-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 265,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04736329",
          "briefTitle": "Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney Functions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Heart Failure With Reduced Ejection Fraction", "Renal Insufficiency"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 107,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03955445",
          "briefTitle": "Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2036-05-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["C3 Glomerulopathy", "Immune-complex-membranoproliferative Glomerulonephritis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 225,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05942053",
          "briefTitle": "Role of Vitamin K2 in Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-07-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01233869",
          "briefTitle": "Bosutinib For Autosomal Dominant Polycystic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-12"
          },
          "completionDateStruct": {
            "date": "2014-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Polycystic Kidney, Autosomal Dominant"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 172,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06819826",
          "briefTitle": "A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-14",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy (IgAN)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 360,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04154787",
          "briefTitle": "Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-01-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Membranous Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07062952",
          "briefTitle": "Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Kidney Tumors", "CKD", "Salt Substitute", "Nephrectomy", "eGFR"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01410448",
          "briefTitle": "Everolimus in de Novo Kidney Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-11"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Transplantation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 383,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07096843",
          "briefTitle": "A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Membranous Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01382303",
          "briefTitle": "Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-10-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-12-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Type 2 Diabetes"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 174,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04743739",
          "briefTitle": "Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Membranous Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02226341",
          "briefTitle": "ACTHar in the Treatment of Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02142881",
          "briefTitle": "Treatment of Masked Hypertension"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06"
          },
          "completionDateStruct": {
            "date": "2017-12-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Masked Hypertension", "Hypertension", "Chronic Renal Insufficiency"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04916132",
          "briefTitle": "Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2043-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Diseases", "Albuminuria", "Diabetic Kidney Disease", "Diabetic Nephropathies", "Diabetes type2", "Molecular Sequence Variation", "Kidney Biopsy"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04287985",
          "briefTitle": "Safety and Efficacy Study of VIS649 for IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Immunoglobulin A Nephropathy", "Glomerular Disease", "IgAN"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 155,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05248646",
          "briefTitle": "Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Immunoglobulin A Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 530,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06890143",
          "briefTitle": "The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Pediatric Hereditary Kidney Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03285711",
          "briefTitle": "Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-02-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Membranous Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02144740",
          "briefTitle": "Effect of NWT-03 on Blood Pressure"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-10"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Blood Pressure", "Albuminuria"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 63,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "35 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03865914",
          "briefTitle": "Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-11-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Kidney Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 2000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01601236",
          "briefTitle": "Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-05"
          },
          "completionDateStruct": {
            "date": "2016-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07098897",
          "briefTitle": "To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy (IgAN)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01712061",
          "briefTitle": "A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-12"
          },
          "completionDateStruct": {
            "date": "2014-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetic Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 226,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04840667",
          "briefTitle": "A Study of Replagal in Treatment-nave Adults With Fabry Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Fabry Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02954419",
          "briefTitle": "IgA Nephropathy Biomarkers Evaluation Study (INTEREST)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11"
          },
          "completionDateStruct": {
            "date": "2027-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["IgA Nephropathy", "Glomerular Diseases"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 2000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01845428",
          "briefTitle": "Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Nephrotic Syndrome", "Hyperlipidemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06676007",
          "briefTitle": "A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["IgA Nephropathy (IgAN)", "Early Initial Therapy"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00879970",
          "briefTitle": "Thiazolidinedione Intervention With Vitamin D Evaluation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-05"
          },
          "completionDateStruct": {
            "date": "2010-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diabetes Mellitus, Type 2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1332,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05458622",
          "briefTitle": "3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus (SLE)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03468972",
          "briefTitle": "Effect of Immunosuppression in IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Biopsy-proven IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 174,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06294236",
          "briefTitle": "Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lupus Erythematosus", "Systemic Lupus Erythematosus", "SLE (Systemic Lupus)", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Granulomatous Polyangiitis", "Microscopic Polyangiitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05852938",
          "briefTitle": "A Study of Zigakibart in Adults With IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-07-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-06-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["IgA Nephropathy", "Immunoglobulin A Nephropathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 383,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03608033",
          "briefTitle": "Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 360,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04053764",
          "briefTitle": "Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-03-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Sickle Cell Disease (SCD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 58,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05097989",
          "briefTitle": "Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lupus Nephritis", "Immunoglobulin A Nephropathy", "IgAN", "LN"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02503735",
          "briefTitle": "Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatitis C", "Chronic Kidney Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03418779",
          "briefTitle": "Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy at High Risk of Developing ESRD"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06046924",
          "briefTitle": "Dietary Acid Reduction and Progression of Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1996-06-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2011-12-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Diseases", "Cardiovascular Diseases", "Hypertension"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 153,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00913393",
          "briefTitle": "Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-02"
          },
          "completionDateStruct": {
            "date": "2010-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Type 2 Diabetes Mellitus", "Diabetic Nephropathy", "Diabetic Kidney Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02006849",
          "briefTitle": "ACTH Treatment of APOL1- Associated Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01"
          },
          "completionDateStruct": {
            "date": "2019-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03832114",
          "briefTitle": "Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Glomerulonephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03598036",
          "briefTitle": "Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Focal Segmental Glomerulosclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06087835",
          "briefTitle": "Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-01-22",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Disease With High Proteinuria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1835,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "95 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02160132",
          "briefTitle": "A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06"
          },
          "completionDateStruct": {
            "date": "2016-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Glomerulonephritis, IGA", "Peripapillary Crescent", "Necrosis", "Steroid Nephropathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 180,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01678898",
          "briefTitle": "Dose-ranging Study of PRX-102 in Adult Fabry Disease Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-03-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Fabry Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02630628",
          "briefTitle": "Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 130,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04221477",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-02-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 271,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04663204",
          "briefTitle": "A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Immunoglobulin A Nephropathy", "Kidney Diseases", "Glomerulonephritis, IGA", "Glomerulonephritis", "Autoimmune Diseases", "Immune System Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05810961",
          "briefTitle": "A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Membranous Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02849444",
          "briefTitle": "A Study to Assess Renal Function Response to Treatment in Patients With Relapsed Multiple Myeloma and Creatinine Clearance"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-09-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 326,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02327403",
          "briefTitle": "Belatacept Conversion in Proteinuric Kidney Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Proteinuria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06090227",
          "briefTitle": "AMPK-activation by Metformin in FSGS: AMP-FSGS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Focal Segmental Glomerulosclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06676384",
          "briefTitle": "Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (18 Years) Primary IgA Nephropathy?"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["IgA Nephropathy", "Renal Insufficiency, Chronic", "IgA Vasculitis", "IGA Glomerulonephritis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 585,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02231138",
          "briefTitle": "Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-09"
          },
          "completionDateStruct": {
            "date": "2016-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1600,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06150924",
          "briefTitle": "Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Kidney Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03995901",
          "briefTitle": "A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Transplanted Organ Rejection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00296400",
          "briefTitle": "Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-02"
          },
          "completionDateStruct": {
            "date": "2009-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hyperlipidemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 237,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06767592",
          "briefTitle": "A Study of Probiotics in IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Nephropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03236350",
          "briefTitle": "Remote Ischaemic Conditioning on Blood Pressure Control in Chronic Kidney Disease Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-11-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Kidney Diseases", "Hypertension", "Cardiovascular Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 85,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04564339",
          "briefTitle": "Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lupus Nephritis", "Immunoglobulin A Nephropathy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 123,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03369236",
          "briefTitle": "A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["C3 Glomerulopathy", "C3 Glomerulonephritis", "Dense Deposit Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "17 Years",
          "maximumAge": "65 Years"
        }
      }
    ]
  }
}
